secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001628280-25-023805
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

The Joint Corp. Q1 revenue up 7% to $13.1M; net loss widens to $506k; reiterates 2025 guidance
--------------------------------------------------------------------------------

- Q1 revenue $13.1M (+7% YoY); system-wide sales $132.6M (+5%); comp sales 3%.
- Net loss from continuing ops $506k ($0.03/share) vs $399k in Q1 2024; adjusted EBITDA from continuing ops $46k vs $425k.
- Reiterated FY2025 guidance: system-wide sales $550-570M; consolidated adj. EBITDA $10-11.5M; new franchised clinics 30-40.
- Sold 9 franchise licenses; opened 5 franchised clinics; total clinics 969 (847 franchised).
- Transitioning to pure-play franchisor with digital marketing and pricing initiatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000162828025023805/0001628280-25-023805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000162828025023805/jynt-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-023805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer